When COVID-19 meets flu season

CHICAGO — As if the COVID-19 pandemic isn’t scary enough, the flu season is not far away. How severe will the flu season be as it converges with the COVID-19 outbreak? What can we do to prepare? Dr. Benjamin Singer, a Northwestern Medicine pulmonologist who treats COVID-19 patients in the intensive care unit, outlines the…

Details

Key grant positions USC as leader in dental and craniofacial tissue regeneration

THE STUDIES SEEM LIKE something straight out of science fiction. There’s one focused on using stem cells to regenerate skull bone for patients with skull defects. Another aims to develop a hydrogel patch that could reduce scarring and regenerate hair follicles and sweat glands in burn victims. Another looks to create a transdermal patch that…

Details

Evolution of pandemic coronavirus outlines path from animals to humans

DURHAM, N.C. — A team of scientists studying the origin of SARS-CoV-2, the virus that has caused the COVID-19 pandemic, found that it was especially well-suited to jump from animals to humans by shapeshifting as it gained the ability to infect human cells. Conducting a genetic analysis, researchers from Duke University, Los Alamos National Laboratory,…

Details

Researchers from Syracuse University and SUNY ESF track COVID-19 in wastewater

Epidemiologist David Larsen, from Syracuse University and microbiologists Hyatt Green, from the College of Environmental Science and Forestry and Frank Middleton, from Upstate Medical University are lead members of a multi-institution research project that is expected to have global application in future efforts to track and contain Sudden Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the…

Details

Oesophageal surgery: Quality increases with larger case volumes

In complex surgery, is there a correlation between the volume of services provided per hospital and the quality of treatment results? This is the question addressed in eight commissions on minimum volumes that the Federal Joint Committee (G-BA) awarded to the Institute for Quality and Efficiency in Health Care (IQWiG). The IQWiG report is now…

Details

RIT scientists develop method to help epidemiologists map spread of COVID-19

Rochester Institute of Technology scientists have developed a method they believe will help epidemiologists more efficiently predict the spread of the COVID-19 pandemic. Their new study, published in Physica D: Nonlinear Phenomena, outlines a solution to the SIR epidemic model, which is commonly used to predict how many people are susceptible to, infected by, and…

Details

Nilotinib appears safe and affects biomarkers in Alzheimer’s disease clinical trial

WASHINGTON — A Georgetown University Medical Center clinical trial investigating the cancer drug nilotinib in people with Alzheimer’s disease finds that it is safe and well-tolerated, and researchers say the drug should be tested in a larger study to further determine its safety and efficacy as a potential disease-modifying strategy. The results of the small,…

Details

New gut-brain link: How gut mucus could help treat brain disorders

Mucus is the first line of defence against bad bacteria in our gut. But could it also be part of our defence against diseases of the brain? Bacterial imbalance in the gut is linked with Alzheimer’s disease, autism and other brain disorders, yet the exact causes are unclear. Now a new research review of 113…

Details

Genestack signs multi-year agreement with AstraZeneca to implement Omics Data Manager

Cambridge, UK, May 2020 — Genestack Ltd. today announced that its flagship multi-omics data catalogue, curation and integrative search product, Omics Data Manager (ODM), has been licensed and implemented by AstraZeneca. Genestack’s ODM is an enabling technology providing a central hub for organising and querying multi-omics data from multiple sites, including transcriptomics and proteomics. Curation…

Details